Histopathological evaluation of fatty and alcoholic liver diseases (Q37811072)

23 August 2017

title

Histopathological evaluation of fatty and alcoholic liver diseases (English)

1 reference

23 August 2017

Lisa Yerian

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21091934

30 August 2024

publication date

1 February 2011

1 reference

full work available at URL

23 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1751-2980.2010.00472.x

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1751-2980.2010.00472.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1751-2980.2010.00472.x/fullpdf

30 August 2024

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1751-2980.2010.00472.X

Journal of Digestive Diseases

30 August 2024

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

17-24

1 reference

The hepatic stellate (Ito) cell: its role in human liver disease

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Prevalence of fatty liver in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Nonalcoholic fatty liver disease: pathology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Pathology of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Histopathology of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2010.00472.X

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-2980.2010.00472.X

The natural history of nonalcoholic fatty liver disease: a clinical histopathological study

30 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1751-2980.2010.00472.X

Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis

30 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1751-2980.2010.00472.X

Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation

30 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1751-2980.2010.00472.X

Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients

30 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1751-2980.2010.00472.X

30 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1751-2980.2010.00472.X

30 August 2024

Identifiers

DOI

1 reference

23 August 2017

1 reference